MedTrace Logo

Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease

NCT03223116 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2017-07-19

No results posted yet for this study

Summary

This study is to evaluate the safety and efficacy of radiofrequency energy procedure for Gastro-esophageal reflux disease (GERD) based on changes of symptoms, medication esophagitis grade, esophageal acid exposure and lower esophageal sphincter pressure. Symptom assessment was performed at baseline and 3, 6, 12 months after treatment.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

PROCEDURE

Radiofrequency delivery

Radiofrequency to the gastroesophageal junction

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • zhaoshen Li, MD · Changhai Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2017-09-01
Completion
2018-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03223116 on ClinicalTrials.gov